drugset / Trial / NCT01499225

A Clinical Trial of YH14642 in Patients With Chronic Periodontal Disease

NCT01499225

Phase 2 Completed 162 enrolled Yuhan Corporation
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is designed to evaluate the efficacy and the safety of YH14642 in Korea patients with chronic periodontitis, in order to investigate the recommended therapeutic dose.

Timeline

Start
2011-12
Primary completion
2013-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Doxycycline hyclate Small molecule 40 mg
Subject YH14642 Unknown 500 mg Oral
Subject YH14642 Unknown 1000 mg Oral
Subject YH14642 Unknown 2000 mg Oral
Comparator Zea mays L. extract Unknown 105 mg

Indications